Tag Archives: Natco Pharma Limited

ILN Today Post

India Grants its First Compulsory License

The Controller General of Patents Designs and Trademarks (“Patent Office”) on March 12, 2012 granted its first ever compulsory license to the Hyderabad based Natco Pharma Limited (“NATCO”) for a cancer drug sold under the brand name “Nexavar” owned by a German based company Bayer Corporation (“Bayer”) and which until now was more or less inaccessible to the common man.

The Patent Office believes that NATCO’s application qualified for the grant of a compulsory license under Section 84 of the Patents Act, 1970 (“PA 70”) on three main grounds, viz.:

Read full article